Literature DB >> 3499609

Recombinant hydrophilic region of murine retroviral protein p15E inhibits stimulated T-lymphocyte proliferation.

D M Schmidt1, N K Sidhu, G J Cianciolo, R Snyderman.   

Abstract

Retroviral envelope protein p15E and antigenically related proteins have been implicated as potential mediators of immune dysfunction associated with retroviral infections and with neoplasia. Due to its extreme hydrophobicity, purified p15E has not been available in a nondenatured form or in sufficient quantities for detailed studies on the mechanisms of its immunosuppressive effects. Therefore, a plasmid was constructed to direct the synthesis in Escherichia coli of the major hydrophilic region of murine p15E. The purified recombinant p15E derivative, soluble under physiological conditions, inhibited by up to 60% (EC50 = 7.5 nM) the anti-CD3-driven proliferation of human T lymphocytes but had no effect on the proliferation of the transformed T-cell line Jurkat. The recombinant protein also inhibited, by up to an average of 92% (EC50 = 2.1 microM), the proliferation of the murine T-cell line CTLL-2. These data (i) provide direct evidence that a retroviral envelope protein can itself inhibit lymphoproliferative function and (ii) map the inhibitory activity to a specific region of p15E. The availability of soluble, recombinant p15E should facilitate studies of the pathogenesis of the immunosuppression accompanying retroviral infections and neoplastic diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499609      PMCID: PMC299278          DOI: 10.1073/pnas.84.20.7290

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Role of antirepressor in the bipartite control of repression and immunity by bacteriophage P22.

Authors:  K Botstein; K K Lew; V Jarvik; C A Swanson
Journal:  J Mol Biol       Date:  1975-02-05       Impact factor: 5.469

2.  Inhibition of lymphocyte transformation by disrupted murine oncornavirus.

Authors:  A K Fowler; D R Twardzik; C D Reed; O S Weislow; A Hellman
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

3.  Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses.

Authors:  G J Cianciolo; T J Matthews; D P Bolognesi; R Snyderman
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

4.  Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein.

Authors:  L E Mathes; R G Olsen; L C Hebebrand; E A Hoover; J P Schaller
Journal:  Nature       Date:  1978-08-17       Impact factor: 49.962

5.  Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants on the p 15(E) and gp70 envelope proteins.

Authors:  M E Lostrom; M R Stone; M Tam; W N Burnette; A Pinter; R C Nowinski
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

6.  Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses.

Authors:  M Mitani; G J Cianciolo; R Snyderman; M Yasuda; R A Good; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.

Authors:  L E Mathes; R G Olsen; L C Hebebrand; E A Hoover; J P Schaller; P W Adams; W S Nichols
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

Review 8.  Intracellular protein degradation in mammalian and bacterial cells: Part 2.

Authors:  A L Goldberg; A C St John
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

9.  Polypeptides of mammalian oncornaviruses. III. Localization of p 15 and reactivity with natural antibody.

Authors:  J N Ihle; M G Hanna; W Schafer; G Hunsmann; D P Bolognesi; G HUPER
Journal:  Virology       Date:  1975-01       Impact factor: 3.616

10.  Polypeptides of mammalian oncornaviruses. II Characterization of murine leukemia virus polypeptide (p 15) bearing interspecies reactivity.

Authors:  W Schafer; G Hunsmann; V Moennig; F Noranha; D P Bolognesi; R W Green; G Hüper
Journal:  Virology       Date:  1975-01       Impact factor: 3.616

View more
  9 in total

1.  Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.

Authors:  C Hoffmann; M R Leitz; S Oberdorf-Maass; M J Lohse; K-N Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-17       Impact factor: 3.000

2.  Biological activities of a synthetic peptide composed of two unlinked domains from a retroviral transmembrane protein sequence.

Authors:  D E Wegemer; K G Kabat; W S Kloetzer
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

Review 3.  Retrovirus and filovirus "immunosuppressive motif" and the evolution of virus pathogenicity in HIV-1, HIV-2, and Ebola viruses.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

4.  Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II.

Authors:  C L Ruegg; C R Monell; M Strand
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

5.  Blockade of type I interferon (IFN) production by retroviral replicating vectors and reduced tumor cell responses to IFN likely contribute to tumor selectivity.

Authors:  Amy H Lin; Cindy Burrascano; Par L Pettersson; Carlos E Ibañez; Harry E Gruber; Douglas J Jolly
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

6.  Computer analysis of the amino acid sequences in gp41 of apathogenic African green monkey (AGM) virus, less pathogenic HIV-2 and highly pathogenic SIV and HIV-1 lentiviruses.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1992-11       Impact factor: 2.332

7.  In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients.

Authors:  J D Kerrebijn; P J Simons; M Tas; A J Balm; H A Drexhage
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

8.  Molecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2.

Authors:  H Y Dai; A Faxvaag; G I Troseth; H Aarset; A Dalen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

9.  Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones.

Authors:  M P Tas; P J Simons; F J Balm; H A Drexhage
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.